the first S-1 was registered 3/8 with a 3/7 pps at $2.35
the second S-1/A was registered 3/20 with a 3/17 pps of $2.05
final registration was for $1.25--a 47% reduction from 3/8 and a 39% from 3/20.
the dip has been to $1 from the $1.25 so a 20% pull back.
to compare, RXII did the same thing, several S-1's filed, around $2/pps, then the final PO at $.90 pps. the stock tanked 20% to $.72, rebounded on pumpy type news (news that really should not have effected the pps), dumped to $.60 then stabilized at the $.75 mark as it approaches catalysts in the next couple of months.
the thought was that RXII could not secure interest without giving a steep discount, maybe the same thing happened here; but the difference being that the CEO of RXII did not buy into the stock like TNDM's, and that RXII CEO has only been purchasing 10k portions on the open market on a trickle while he makes half a million in salary. note that TNDM's CEO purchased 4 year's salary at the $1.25 share offer; i would say that is a steep difference in the vote of confidence.
if there is a 33% pull back from the offer, i will have to ride it out, but i think 20% may be where this one settles, as that $2million dollar purchase by the CEO is an awful lot of sweetener to offset the bitter.
i am a novice trader, as everyday is a new day on the market.
Recent TNDM News
- Tandem t:slim X2 Insulin Pump Now Compatible with Lyumjev Ultra-rapid Acting Insulin in European Union • Business Wire • 09/19/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 09:06:21 PM
- Tandem Diabetes Care Announces Upcoming Conference Participation • Business Wire • 08/26/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 12:31:52 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 12:31:41 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 12:31:21 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 12:31:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 12:31:00 AM
- Tandem Diabetes Care to Release Updated iOS t:connect Mobile App for t:slim X2 Insulin Pump Users Impacted by March 2024 Nationwide Recall • Business Wire • 08/19/2024 10:30:00 PM
- Tandem Diabetes Care Provides Update on March 2024 Nationwide Recall of t:connect Mobile App for iOS Devices • Business Wire • 08/12/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/09/2024 08:52:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:11:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:07:59 PM
- Tandem Diabetes Care Announces Second Quarter 2024 Financial Results and Increases Full Year 2024 Sales Guidance • Business Wire • 08/01/2024 08:05:00 PM
- Tandem Diabetes Care Announces Upcoming Conference Presentation • Business Wire • 07/30/2024 08:05:00 PM
- Tandem Diabetes Care and Dexcom Announce the t:slim X2 Insulin Pump with Dexcom G7 CGM Compatibility is Authorized for Sale by Health Canada • Business Wire • 07/29/2024 01:00:00 PM
- Tandem Diabetes Care et Dexcom annoncent que la pompe à insuline t:slim X2 compatible avec le système de SGC Dexcom G7 est autorisée à la vente par Santé Canada • Business Wire • 07/29/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:16:51 PM
- Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024 • Business Wire • 07/11/2024 08:05:00 PM
- Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions • Business Wire • 06/22/2024 03:00:00 PM
- Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer • Business Wire • 06/20/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 08:31:22 PM
- Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association’s 84th Scientific Sessions • Business Wire • 06/18/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:10:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/12/2024 09:39:07 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM